OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001385818

AYTU BIOPHARMA, INC (AYTU)

AYTU BIOPHARMA, INC (CIK 0001385818, ticker AYTU, EIN 47-0883144) reported revenue of $57.57 million ($57,570,000) for FY2026 (2025-07-01 to 2026-06-30) and net income of -$14.25 million (-$14,252,000) for FY2026 (2025-07-01 to 2026-06-30), as filed in its 10-K filed 2026-09-22 (accession 0001437749-26-030908).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends June 30).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001385818
TickersAYTU (Nasdaq)
EIN47-0883144
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endJune 30
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_146hrcrm9kktthbep1nkyqk575
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$57,570,000FY20262025-07-01 to 2026-06-3010-K2026-09-220001437749-26-030908RevenueFromContractWithCustomerExcludingAssessedTax
Net income-$14,252,000FY20262025-07-01 to 2026-06-3010-K2026-09-220001437749-26-030908NetIncomeLoss
Total assets$105,007,000FY2026as of 2026-06-3010-K2026-09-220001437749-26-030908Assets
Total liabilities$97,106,000FY2023as of 2023-06-3010-K2023-10-120001558370-23-016393Liabilities
Stockholders' equity$35,274,000FY2026as of 2026-06-3010-K2026-09-220001437749-26-030908StockholdersEquity
Operating cash flow$3,281,000FY20262025-07-01 to 2026-06-3010-K2026-09-220001437749-26-030908NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$5.11 per shareFY20232022-07-01 to 2023-06-3010-K2023-10-120001558370-23-016393EarningsPerShareDiluted
Shares outstanding10,866,708 sharesFY2026as of 2026-09-1510-K2026-09-220001437749-26-030908EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2017-2026, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20262025-07-01 to 2026-06-30$57,570,00010-K2026-09-220001437749-26-030908
RevenueFY20252024-07-01 to 2025-06-30$66,382,00010-K2026-09-220001437749-26-030908
RevenueFY20242023-07-01 to 2024-06-30$65,183,00010-K2025-09-230001437749-25-029723
RevenueFY20232022-07-01 to 2023-06-30$107,399,00010-K2024-09-260001437749-24-030062
RevenueFY20222021-07-01 to 2022-06-30$96,669,00010-K2023-10-120001558370-23-016393
RevenueFY20212020-07-01 to 2021-06-30$65,632,00010-K2022-09-270001558370-22-014652
RevenueFY20202019-07-01 to 2020-06-30$27,632,08010-K2020-10-060001654954-20-010891
RevenueFY20202018-07-01 to 2019-06-30$7,320,35710-K2020-10-060001654954-20-010891
RevenueFY20182017-07-01 to 2018-06-30$3,660,12010-K2019-09-260001654954-19-011147
RevenueFY20172016-07-01 to 2017-06-30$3,221,59010-K2018-09-060001213900-18-012209
Net incomeFY20262025-07-01 to 2026-06-30-$14,252,00010-K2026-09-220001437749-26-030908
Net incomeFY20252024-07-01 to 2025-06-30-$13,562,00010-K2026-09-220001437749-26-030908
Net incomeFY20242023-07-01 to 2024-06-30-$15,844,00010-K2025-09-230001437749-25-029723
Net incomeFY20232022-07-01 to 2023-06-30-$17,051,00010-K2024-09-260001437749-24-030062
Net incomeFY20222021-07-01 to 2022-06-30-$108,779,00010-K2023-10-120001558370-23-016393
Net incomeFY20212020-07-01 to 2021-06-30-$58,289,00010-K2022-09-270001558370-22-014652
Net incomeFY20202019-07-01 to 2020-06-30-$13,621,00010-K2021-09-280001558370-21-012825
Net incomeFY20202018-07-01 to 2019-06-30-$27,131,90810-K2020-10-060001654954-20-010891
Net incomeFY20182017-07-01 to 2018-06-30-$10,187,86310-K2019-09-260001654954-19-011147
Net incomeFY20172016-07-01 to 2017-06-30-$22,508,30410-K2018-09-060001213900-18-012209
  • Revenue for FY2024 was restated: first reported as $81,002,000 (accession 0001437749-24-030062, filed 2024-09-26).
  • Net income for FY2022 was restated: first reported as -$110,173,000 (accession 0001558370-22-014652, filed 2022-09-27).
  • Net income for FY2020 was restated: first reported as -$13,620,679 (accession 0001654954-20-010891, filed 2020-10-06).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-K2026-09-222026-06-300001437749-26-030908aytu20260630_10k.htm
10-Q2026-05-132026-03-310001437749-26-016721aytu20260331_10q.htm
10-Q2026-02-032025-12-310001437749-26-002804aytu20251231_10q.htm
10-Q2025-11-132025-09-300001437749-25-034825aytu20250930_10q.htm
10-K2025-09-232025-06-300001437749-25-029723aytu20250630c_10k.htm
10-Q2025-05-142025-03-310001437749-25-016833aytu20250331_10q.htm
10-Q2025-02-122024-12-310001437749-25-003568aytu20241231c_10q.htm
10-Q2024-11-132024-09-300001437749-24-034970aytu20240930_10q.htm
10-K2024-09-262024-06-300001437749-24-030062aytu20240630_10k.htm
10-Q2024-05-152024-03-310001437749-24-017051aytu20240331_10q.htm
10-Q2024-02-142023-12-310001437749-24-004149aytu20231231_10q.htm
10-Q2023-11-142023-09-300001558370-23-019015aytu-20230930x10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001385818published by the sourcedata.sec.gov/submissions/CIK0001385818.json2026-10-21
Employer Identification Number (EIN) · US-EIN47-0883144published by the sourcedata.sec.gov/submissions/CIK0001385818.json2026-10-21

Former names

NameFromTo
AYTU BIOSCIENCE, INC2015-06-092021-03-22
Rosewind CORP2007-01-112015-06-08

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001385818.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001385818.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001385818" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001385818/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001385818/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1385818"}

On SEC EDGAR

About this data